MG
Michael Greiner
Former Interim CEO

Michael Greiner insider trades: Avanos Medical (AVNS) stock sales

Former Interim CEO, Avanos Medical Last trade Mar 14, 2024 45 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2012
4
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 14, 2024AVNS↓ Sell$153K
Nov 7, 2018ANGO↓ Sell$42K
Aug 18, 2014VPRT↓ Sell$48K
May 15, 2014VPRT↓ Sell$40K
Nov 15, 2013VPRT↓ Sell$30K
Aug 19, 2013VPRT↓ Sell$41K
May 15, 2013VPRT↓ Sell$26K
Feb 21, 2013VPRT↓ Sell$30K
Aug 16, 2012VPRT↓ Sell$16K
May 18, 2012VPRT↓ Sell$67K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AVNS insiders

Open-market trades in the last 12 months

About Michael Greiner's insider trades

Michael Greiner is Former Interim CEO at Avanos Medical (AVNS). Since May 18, 2012, Michael has reported no open-market purchases and 10 sales worth $492K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include shares withheld for taxes (25 filings), grants and awards (18 filings), option exercises (14 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVNS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.